Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients

H Maagdenberg; MB Bierings; Heleen van Ommen; FJM van der Meer; IM Appel; RYJ Tamminga; S le Cessie; JJ Swen; T Straaten; A Boer; AH Zee

doi:10.2217/pgs-2018-0095

Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients

H Maagdenberg, MB Bierings, Heleen van Ommen, FJM van der Meer, IM Appel, RYJ Tamminga, S le Cessie, JJ Swen, T Straaten, A Boer, AH Zee

Pediatrics

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1195-1202
Number of pages	8
Journal	Pharmacogenomics
Volume	19
Issue number	15
DOIs	https://doi.org/10.2217/pgs-2018-0095
Publication status	Published - 2018

Research programs

EMC MM-02-54-03

Access to Document

10.2217/pgs-2018-0095

http://hdl.handle.net/1765/110929

Cite this

@article{92f183eb7d4b4fbe9b744150b01767e1,

title = "Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients",

author = "H Maagdenberg and MB Bierings and \{van Ommen\}, Heleen and \{van der Meer\}, FJM and IM Appel and RYJ Tamminga and \{le Cessie\}, S and JJ Swen and T Straaten and A Boer and AH Zee",

year = "2018",

doi = "10.2217/pgs-2018-0095",

language = "Undefined/Unknown",

volume = "19",

pages = "1195--1202",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor \& Francis Ltd",

number = "15",

}

TY - JOUR

T1 - Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients

AU - Maagdenberg, H

AU - Bierings, MB

AU - van Ommen, Heleen

AU - van der Meer, FJM

AU - Appel, IM

AU - Tamminga, RYJ

AU - le Cessie, S

AU - Swen, JJ

AU - Straaten, T

AU - Boer, A

AU - Zee, AH

PY - 2018

Y1 - 2018

U2 - 10.2217/pgs-2018-0095

DO - 10.2217/pgs-2018-0095

M3 - Article

C2 - 30207196

SN - 1462-2416

VL - 19

SP - 1195

EP - 1202

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 15

ER -